Evidence map›Paper›PMID 38645450›Full record

ArticleFrontiers in public health2024

Translating the COVID-19 epidemiological situation into policies and measures: the Belgian experience.

Géraldine De Muylder, Valeska Laisnez, Giulietta Stefani, Caroline Boulouffe, Christel Faes, Naïma Hammami, Pierre Hubin, Geert Molenberghs, Jasper Sans, Cecile van de Konijnenburg and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Respi-Radar: a tool to monitor respiratory infections, Belgium, winter season 2023/24.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Géraldine De MuylderDepartment of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Valeska LaisnezDepartment of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Giulietta StefaniDepartment of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Caroline BoulouffeAgence pour une Vie de Qualité (AVIQ), Charleroi, Belgium.
Christel FaesData Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.
Naïma HammamiDepartment of Care, Team Infection Prevention and Vaccination, Brussels, Belgium.
Pierre HubinDepartment of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Geert MolenberghsData Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.
Jasper SansDepartment of Infectious Disease Prevention, Brussels, Belgium.
Cecile van de KonijnenburgFederal Public Service - Public Health - Risk Management Group, Brussels, Belgium.
Stefaan Van der BorghtFederal Public Service - Public Health - Risk Management Group, Brussels, Belgium.
Ruben BrondeelDepartment of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Jorgen StassijnsCrisis Management and Strategy, Sciensano, Brussels, Belgium.
Tinne LernoutDepartment of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic led to sustained surveillance efforts, which made unprecedented volumes and types of data available. In Belgium, these data were used to conduct a targeted and regular assessment of the epidemiological situation. In addition, management tools were developed, incorporating key indicators and thresholds, to define risk levels and offer guidance to policy makers. Categorizing risk into various levels provided a stable framework to monitor the COVID-19 epidemiological situation and allowed for clear communication to authorities. Although translating risk levels into specific public health measures has remained challenging, this experience was foundational for future evaluation of the situation for respiratory infections in general, which, in Belgium, is now based on a management tool combining different data sources.

Indexed as

COVID-19BelgiumHealth PolicyHumansPandemicsPublic HealthRisk AssessmentSARS-CoV-2barometerCOVID-19datamanagement toolpoliciesrisk management

Identifiers

PMID38645450
PMCPMC11026715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.